Accurate detection of low prevalence AKT1 E17K mutation in tissue or plasma from advanced cancer patients

Personalized healthcare relies on accurate companion diagnostic assays that enable the most appropriate treatment decision for cancer patients. Extensive assay validation prior to use in a clinical setting is essential for providing a reliable test result. This poses a challenge for low prevalence m...

Descripción completa

Detalles Bibliográficos
Autores principales: de Bruin, Elza C., Whiteley, Jessica L., Corcoran, Claire, Kirk, Pauline M., Fox, Jayne C., Armisen, Javier, Lindemann, Justin P. O., Schiavon, Gaia, Ambrose, Helen J., Kohlmann, Alexander
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5417426/
https://www.ncbi.nlm.nih.gov/pubmed/28472036
http://dx.doi.org/10.1371/journal.pone.0175779

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5417426/
https://www.ncbi.nlm.nih.gov/pubmed/28472036
http://dx.doi.org/10.1371/journal.pone.0175779

Ejemplares similares